Healthcare+ Carpmaels & Ransford recognised in The Legal 500 UK 2027 rankingsFirm and individual recognition across patent, life sciences and trade mark categoriesRead More 01Oct2026 Innovation in FemTech: personal health and wellness"When women take care of their health, they become their own best friend." - Maya AngelouRead More 24Aug2026 UK IPO’s new software patent guidance: progress, but not a revolutionThe UK IPO’s updated guidance should reduce Section 1(2) objections, but applicants may still face difficult questions about which claim features make a technical contributionRead More 15Jul2026 Life Sciences Awards 2026 EMEACarpmaels & Ransford wins three awardsRead More 05Jun2026 Advocate General in C 456/24 Halozyme: The MA has the final say on what constitutes an “active ingredient”A substance expressly designated in the marketing authorisation as an excipient cannot be regarded as an active ingredient for SPC purposes, according to AG EmiliouRead More 23Apr2026 Innovation in FemTechIntroducing our new article series exploring emerging technologies and IPRead More 08Apr2026 Managing IP Rankings 202525 Carpmaels practitioners recommended in this year’s rankingsRead More 06Oct2025 Belgian Patent Court weighs in on the requirements and scope of the manufacturing waiverWe look into the manufacturing waiver and how the Belgian Courts applied itRead More 09Sep2025 UK SPC law – changes as of 1st January 2025The UK’s SPC system has adjusted to the UK’s new regulatory regime under the Windsor FrameworkRead More 01Sep2025 A checkpoint for antibody SPC applications in France?The French Supreme Court offers a new take on the interpretation of Article 3(a), as applied to an SPC application for an antibody that acts as an immune checkpoint inhibitorRead More 01Sep202512345> Type Firm News Insights PodcastsServiceProtectDealDisputeUPCSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026OctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
